SODIUM ZIRCONIUM CYCLOSILICATE

SODIUM ZIRCONIUM CYCLOSILICATE was reported 4008 times

SODIUM ZIRCONIUM CYCLOSILICATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTED TOMOGRAPHIC GASTROGRAPHY 1 1.0000
1 SPECIFIC GRAVITY BODY FLUID INCREASED 2 0.2500
2 X-RAY GASTROINTESTINAL TRACT ABNORMAL 11 0.1528
3 BLEEDING TIME 1 0.1429
4 IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 3 0.1154
5 REPERFUSION ARRHYTHMIA 6 0.0984
6 LIPIDOSIS 6 0.0984
7 STOMACH SCAN ABNORMAL 2 0.0714
8 CORROSIVE GASTRITIS 1 0.0588
9 BURKHOLDERIA TEST POSITIVE 5 0.0403
10 BLOOD CREATINE 1 0.0345
11 RED BLOOD CELL ELLIPTOCYTES PRESENT 2 0.0260
12 IMMOBILISATION SYNDROME 5 0.0235
13 BLOOD POTASSIUM 1 0.0222
14 BLOOD POTASSIUM ABNORMAL 55 0.0206
15 PLEURAL CALCIFICATION 2 0.0174
16 ACQUIRED CYSTIC KIDNEY DISEASE 1 0.0172
17 RHYTHM IDIOVENTRICULAR 5 0.0154
18 GENITAL ULCERATION 10 0.0130
19 BLOOD POTASSIUM INCREASED 206 0.0127
20 SEVERE CUTANEOUS ADVERSE REACTION 3 0.0126
21 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 1 0.0123
22 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 1 0.0109
23 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL 2 0.0103
24 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
25 ANAL EROSION 1 0.0091
26 BLOOD BICARBONATE ABNORMAL 1 0.0089
27 ARTERIOVENOUS FISTULA THROMBOSIS 3 0.0087
28 ALBUMIN GLOBULIN RATIO DECREASED 2 0.0086
29 COMPLEMENT FACTOR C3 DECREASED 2 0.0082
30 SHUNT OCCLUSION 4 0.0079
31 LIPID METABOLISM DISORDER 3 0.0078
32 SINGLE FUNCTIONAL KIDNEY 5 0.0076
33 DECOMPENSATED HYPOTHYROIDISM 1 0.0074
34 CERVICOGENIC HEADACHE 1 0.0074
35 SHUNT STENOSIS 2 0.0072
36 CRYOGLOBULINAEMIA 5 0.0070
37 BLOOD CREATININE 1 0.0065
38 GASTRIC HYPOMOTILITY 2 0.0065
39 ABSCESS SOFT TISSUE 1 0.0065
40 PROTEIN DEFICIENCY 2 0.0064
41 RIGHT VENTRICULAR ENLARGEMENT 2 0.0063
42 BLOOD CHLORIDE ABNORMAL 1 0.0062
43 METABOLIC FUNCTION TEST ABNORMAL 2 0.0061
44 BLOOD OSMOLARITY INCREASED 2 0.0061
45 APPLICATION SITE WOUND 1 0.0061
46 LOWER URINARY TRACT SYMPTOMS 2 0.0055
47 CEREBRAL VENTRICULAR RUPTURE 1 0.0055
48 HYPERTENSIVE URGENCY 3 0.0054
49 ACETABULUM FRACTURE 2 0.0053
50 BLOOD TEST 1 0.0053
51 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 1 0.0053
52 THROMBOTIC CEREBRAL INFARCTION 2 0.0053
53 HYPERKALAEMIA 186 0.0053
54 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
55 COMPUTERISED TOMOGRAM ABNORMAL 11 0.0049
56 BLOOD SODIUM INCREASED 13 0.0048
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
58 CRYSTAL DEPOSIT INTESTINE 1 0.0047
59 BENDOPNOEA 1 0.0045
60 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 3 0.0045
61 BEZOAR 6 0.0043
62 CARBON DIOXIDE DECREASED 5 0.0043
63 SCROTAL OEDEMA 3 0.0042
64 PNEUMONIA HAEMOPHILUS 2 0.0041
65 BLOOD CHLORIDE INCREASED 7 0.0040
66 CHRONIC DISEASE 1 0.0039
67 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
68 RECTAL PERFORATION 2 0.0037
69 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
70 GLOMERULONEPHRITIS 9 0.0037
71 CATHETER SITE THROMBOSIS 1 0.0036
72 DENTAL PLAQUE 1 0.0036
73 MECHANICAL ILEUS 2 0.0035
74 CARDIORENAL SYNDROME 2 0.0035
75 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
76 METHAEMOGLOBINAEMIA 8 0.0035
77 CATHETER SITE CELLULITIS 1 0.0034
78 MEAN PLATELET VOLUME INCREASED 2 0.0033
79 END STAGE RENAL DISEASE 60 0.0033
80 COMPLICATIONS OF TRANSPLANTED LUNG 1 0.0033
81 BLOOD BILIRUBIN DECREASED 2 0.0032
82 PRODUCT RESIDUE PRESENT 17 0.0031
83 HYPERCHLORAEMIA 2 0.0031
84 SHORT-BOWEL SYNDROME 2 0.0031
85 RENAL TRANSPLANT 11 0.0030
86 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
87 CUBITAL TUNNEL SYNDROME 1 0.0029
88 OESOPHAGITIS ULCERATIVE 2 0.0029
89 COLOSTOMY CLOSURE 1 0.0029
90 PLEURAL THICKENING 2 0.0029
91 CAROTID ARTERY ANEURYSM 1 0.0029
92 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
93 CARDIAC AMYLOIDOSIS 3 0.0027
94 NORMOCYTIC ANAEMIA 4 0.0027
95 BILE DUCT STENT INSERTION 1 0.0026
96 BREATH HOLDING 1 0.0026
97 CRITICAL ILLNESS 2 0.0026
98 CARDIAC VENTRICULAR DISORDER 1 0.0024
99 ADRENAL MASS 2 0.0024
100 HYPERPARATHYROIDISM SECONDARY 6 0.0024
101 NEPHROGENIC ANAEMIA 11 0.0024
102 DIABETIC NEPHROPATHY 5 0.0023
103 AORTIC VALVE STENOSIS 4 0.0022
104 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
105 BODY MASS INDEX DECREASED 1 0.0022
106 BLOOD CHOLESTEROL 1 0.0021
107 BLOOD BICARBONATE INCREASED 1 0.0021
108 BLOOD URIC ACID DECREASED 1 0.0021
109 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
110 BRAIN STEM STROKE 1 0.0020
111 HYPERVOLAEMIA 10 0.0020
112 DROWNING 2 0.0020
113 MARASMUS 3 0.0020
114 BLADDER OBSTRUCTION 1 0.0019
115 BLOOD ALBUMIN ABNORMAL 1 0.0019
116 ALBUMINURIA 1 0.0019
117 CORNEAL EROSION 1 0.0019
118 BODY FAT DISORDER 1 0.0018
119 ADRENAL HAEMORRHAGE 1 0.0018
120 CATHETER SITE INFLAMMATION 1 0.0018
121 ENTERITIS INFECTIOUS 3 0.0018
122 PERIPHERAL VASCULAR DISORDER 9 0.0017
123 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
124 COLON CANCER STAGE IV 1 0.0017
125 ESSENTIAL HYPERTENSION 3 0.0016
126 HYPERNATRAEMIA 8 0.0016
127 RENAL ATROPHY 2 0.0016
128 FRACTURED COCCYX 2 0.0016
129 FAECAL CALPROTECTIN INCREASED 5 0.0016
130 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
131 HYPOKALAEMIA 72 0.0016
132 OBSTRUCTION GASTRIC 2 0.0016
133 BLOOD POTASSIUM DECREASED 46 0.0015
134 ANION GAP INCREASED 2 0.0015
135 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
136 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
137 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
138 CUTANEOUS SYMPTOM 1 0.0015
139 DIVERTICULAR PERFORATION 3 0.0015
140 HYPERPARATHYROIDISM 3 0.0015
141 DISCHARGE 2 0.0014
142 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
143 PRERENAL FAILURE 2 0.0014
144 APPENDIX DISORDER 2 0.0014
145 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
146 DIABETIC FOOT INFECTION 2 0.0014
147 HYPERPHOSPHATAEMIA 3 0.0014
148 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
149 ATROPHIC VULVOVAGINITIS 1 0.0014
150 PULMONARY VALVE INCOMPETENCE 2 0.0014
151 CARDIAC FAILURE ACUTE 9 0.0013
152 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
153 DEATH 1159 0.0013
154 DIALYSIS 19 0.0013
155 CHOLANGITIS ACUTE 1 0.0013
156 BLOOD LOSS ANAEMIA 3 0.0013
157 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
158 BASOPHIL COUNT INCREASED 1 0.0013
159 URINE ABNORMALITY 6 0.0013
160 INTELLECTUAL DISABILITY 2 0.0013
161 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
162 OEDEMA 70 0.0013
163 FAECALOMA 7 0.0013
164 BLOOD FIBRINOGEN INCREASED 1 0.0013
165 BREAST CALCIFICATIONS 1 0.0013
166 AZOTAEMIA 5 0.0013
167 ACUTE PULMONARY OEDEMA 7 0.0012
168 SKIN EROSION 4 0.0012
169 BASAL GANGLIA HAEMORRHAGE 1 0.0012
170 BALANOPOSTHITIS 1 0.0012
171 SUFFOCATION FEELING 3 0.0012
172 ILEUS 15 0.0012
173 ANTIBODY TEST POSITIVE 2 0.0012
174 CAMPYLOBACTER INFECTION 1 0.0012
175 VASODILATATION 3 0.0012
176 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 2 0.0012
177 CARDIAC FAILURE 95 0.0012
178 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
179 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
180 CARDIAC FAILURE CHRONIC 5 0.0012
181 LAZINESS 2 0.0012
182 COLONIC ABSCESS 1 0.0012
183 CATHETER SITE PAIN 3 0.0012
184 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
185 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
186 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
187 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
188 BLOOD MAGNESIUM INCREASED 1 0.0011
189 INABILITY TO AFFORD MEDICATION 11 0.0011
190 ANEURYSM RUPTURED 1 0.0011
191 IMMUNE-MEDIATED MYOSITIS 3 0.0011
192 PNEUMOPERITONEUM 2 0.0011
193 NEPHROPATHY 10 0.0011
194 BLOOD UREA ABNORMAL 1 0.0011
195 PROTEIN TOTAL DECREASED 4 0.0011
196 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
197 DUODENAL ULCER HAEMORRHAGE 3 0.0010
198 CHRONIC KIDNEY DISEASE 79 0.0010
199 BLOOD URINE 1 0.0010
200 BLADDER CATHETERISATION 1 0.0010
201 ANIMAL SCRATCH 1 0.0010
202 BLOOD IRON ABNORMAL 1 0.0010
203 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
204 DIPLEGIA 2 0.0010
205 RENAL DISORDER 47 0.0010
206 CEREBROVASCULAR DISORDER 3 0.0010
207 QUADRIPLEGIA 2 0.0010
208 WALKING DISABILITY 2 0.0010
209 BLAST CELL COUNT INCREASED 1 0.0010
210 BLOOD SODIUM ABNORMAL 1 0.0009
211 CUSHINGOID 3 0.0009
212 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
213 RENAL IMPAIRMENT 78 0.0009
214 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
215 BLADDER DILATATION 1 0.0009
216 CLAUSTROPHOBIA 1 0.0009
217 RENAL TUBULAR ACIDOSIS 2 0.0009
218 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
219 ACINETOBACTER INFECTION 1 0.0009
220 BOWEL MOVEMENT IRREGULARITY 7 0.0009
221 BLOOD ALBUMIN DECREASED 7 0.0009
222 BLOOD FIBRINOGEN DECREASED 1 0.0009
223 BLOOD CREATININE ABNORMAL 3 0.0009
224 LUNG TRANSPLANT 3 0.0008
225 COCCIDIOIDOMYCOSIS 1 0.0008
226 LACUNAR INFARCTION 2 0.0008
227 BILE DUCT STENOSIS 1 0.0008
228 PULSE ABNORMAL 2 0.0008
229 CARDIAC DEATH 1 0.0008
230 MONOCYTE COUNT INCREASED 3 0.0008
231 CEREBRAL ARTERY EMBOLISM 1 0.0008
232 THROMBOTIC MICROANGIOPATHY 8 0.0008
233 AMPUTATION 1 0.0008
234 BLOOD CALCIUM DECREASED 9 0.0008
235 CATHETER SITE HAEMORRHAGE 2 0.0008
236 AORTIC VALVE REPLACEMENT 1 0.0008
237 CATHETER SITE INFECTION 3 0.0008
238 PROTEINURIA 15 0.0008
239 BRONCHIAL SECRETION RETENTION 1 0.0008
240 BLOOD UREA INCREASED 13 0.0008
241 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
242 HYPOALBUMINAEMIA 6 0.0008
243 FAECES HARD 3 0.0008
244 HEPATITIS TOXIC 2 0.0008
245 URINE OUTPUT INCREASED 2 0.0008
246 STEVENS-JOHNSON SYNDROME 17 0.0008
247 PRODUCT PREPARATION ISSUE 5 0.0008
248 EXFOLIATIVE RASH 2 0.0008
249 DYSGRAPHIA 5 0.0008
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
251 BLOOD CREATININE INCREASED 49 0.0007
252 STEATORRHOEA 2 0.0007
253 BODY MASS INDEX INCREASED 1 0.0007
254 HOMICIDAL IDEATION 3 0.0007
255 GASTRIC PERFORATION 2 0.0007
256 CARBON DIOXIDE INCREASED 1 0.0007
257 ASPIRATION 8 0.0007
258 CORNEAL ABRASION 1 0.0007
259 VITREOUS HAEMORRHAGE 2 0.0007
260 LARGE INTESTINE PERFORATION 5 0.0007
261 ENDOTRACHEAL INTUBATION 2 0.0007
262 BRASH SYNDROME 1 0.0007
263 INTESTINAL PERFORATION 8 0.0007
264 RENAL TUBULAR DISORDER 2 0.0007
265 RENAL FAILURE 94 0.0007
266 CATAPLEXY 1 0.0007
267 AORTIC VALVE INCOMPETENCE 3 0.0007
268 MYOPATHY 6 0.0007
269 ENTEROCOLITIS 4 0.0007
270 BLOOD SODIUM DECREASED 13 0.0007
271 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
272 GASTROINTESTINAL NECROSIS 2 0.0007
273 BILIARY DILATATION 1 0.0007
274 METABOLIC ENCEPHALOPATHY 2 0.0007
275 CHOKING 13 0.0007
276 THYROIDITIS 2 0.0007
277 TYPE 1 DIABETES MELLITUS 4 0.0007
278 SUSPECTED OFF LABEL USE 3 0.0007
279 HYPERCAPNIA 2 0.0007
280 ABDOMINAL HERNIA 3 0.0007
281 TROPONIN INCREASED 5 0.0007
282 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
283 DUODENITIS 2 0.0007
284 CALCULUS URINARY 1 0.0006
285 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
286 RENAL FUNCTION TEST ABNORMAL 3 0.0006
287 BLINDNESS 26 0.0006
288 RESPIRATORY RATE DECREASED 2 0.0006
289 FOREIGN BODY IN THROAT 2 0.0006
290 NON-CARDIAC CHEST PAIN 2 0.0006
291 AORTIC VALVE DISEASE 1 0.0006
292 BACTERIAL SEPSIS 2 0.0006
293 BRADYARRHYTHMIA 1 0.0006
294 INFUSION SITE HAEMORRHAGE 2 0.0006
295 ANEURYSM 3 0.0006
296 PROTEIN URINE PRESENT 3 0.0006
297 NEPHRITIS 2 0.0006
298 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
299 METABOLIC ACIDOSIS 19 0.0006
300 DRUG TOLERANCE 3 0.0006
301 PRODUCT TASTE ABNORMAL 8 0.0006
302 BACTERAEMIA 7 0.0006
303 WOUND COMPLICATION 2 0.0006
304 CONSTIPATION 127 0.0006
305 AORTIC STENOSIS 2 0.0006
306 CARDIAC FAILURE CONGESTIVE 46 0.0006
307 ACUTE RESPIRATORY FAILURE 11 0.0006
308 BREAST DISCHARGE 1 0.0006
309 BLOOD LACTIC ACID INCREASED 3 0.0006
310 CARDIOMEGALY 7 0.0006
311 TUMOUR LYSIS SYNDROME 5 0.0006
312 GENERALISED OEDEMA 7 0.0006
313 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
314 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
315 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
316 CARDIAC ABLATION 1 0.0006
317 ACUTE KIDNEY INJURY 84 0.0005
318 CONDUCTION DISORDER 1 0.0005
319 INTESTINAL ISCHAEMIA 3 0.0005
320 PNEUMONIA BACTERIAL 5 0.0005
321 IRON DEFICIENCY ANAEMIA 5 0.0005
322 HYPERTENSIVE CRISIS 6 0.0005
323 COLON CANCER 8 0.0005
324 ERYTHEMA MULTIFORME 5 0.0005
325 BLOOD BICARBONATE DECREASED 1 0.0005
326 TONGUE OEDEMA 2 0.0005
327 ADRENAL DISORDER 1 0.0005
328 PNEUMONIA ASPIRATION 13 0.0005
329 DEVICE RELATED INFECTION 8 0.0005
330 ELECTROLYTE IMBALANCE 6 0.0005
331 ABDOMINAL WALL HAEMATOMA 1 0.0005
332 CONCOMITANT DISEASE PROGRESSION 1 0.0005
333 LYMPHOCYTE COUNT DECREASED 9 0.0005
334 THERAPY CHANGE 5 0.0005
335 TRICUSPID VALVE INCOMPETENCE 4 0.0005
336 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
337 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
338 BLEPHARITIS 2 0.0005
339 HEPATITIS CHOLESTATIC 3 0.0005
340 CARDIAC DISCOMFORT 1 0.0005
341 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
342 CHEST INJURY 1 0.0005
343 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
344 GASTROINTESTINAL PERFORATION 2 0.0005
345 FLUID OVERLOAD 7 0.0005
346 MOUTH ULCERATION 10 0.0005
347 SUDDEN DEATH 5 0.0005
348 POOR PERIPHERAL CIRCULATION 2 0.0005
349 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
350 DEMENTIA 13 0.0005
351 METASTATIC NEOPLASM 2 0.0005
352 APPLICATION SITE SCAB 1 0.0005
353 PHARYNGITIS STREPTOCOCCAL 5 0.0005
354 IMMOBILE 2 0.0005
355 URINE OUTPUT DECREASED 4 0.0005
356 DIVERTICULUM INTESTINAL 2 0.0005
357 COLONOSCOPY 1 0.0005
358 HAEMATOCRIT DECREASED 9 0.0005
359 ACCIDENT AT WORK 1 0.0005
360 FLUID RETENTION 23 0.0005
361 BLOOD CREATINE INCREASED 2 0.0005
362 CATHETERISATION CARDIAC 2 0.0005
363 ILEUS PARALYTIC 2 0.0004
364 GASTROINTESTINAL INFECTION 4 0.0004
365 RASH PAPULAR 10 0.0004
366 NEPHROPATHY TOXIC 5 0.0004
367 BRONCHIECTASIS 3 0.0004
368 COLITIS ISCHAEMIC 3 0.0004
369 METASTASES TO LYMPH NODES 3 0.0004
370 FEEDING DISORDER 9 0.0004
371 PLEURAL EFFUSION 27 0.0004
372 CHRONIC GASTRITIS 1 0.0004
373 ASCITES 13 0.0004
374 IMPAIRED GASTRIC EMPTYING 6 0.0004
375 HAEMOGLOBIN INCREASED 2 0.0004
376 HYPERTRANSAMINASAEMIA 3 0.0004
377 PERFORMANCE STATUS DECREASED 2 0.0004
378 BLINDNESS UNILATERAL 6 0.0004
379 ARTERIOSCLEROSIS 4 0.0004
380 BLOOD IRON DECREASED 5 0.0004
381 GASTRIC ULCER 8 0.0004
382 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
383 KIDNEY TRANSPLANT REJECTION 2 0.0004
384 HUMERUS FRACTURE 2 0.0004
385 PRODUCT PRESCRIBING ISSUE 9 0.0004
386 DIZZINESS POSTURAL 4 0.0004
387 OEDEMA PERIPHERAL 50 0.0004
388 CEREBRAL INFARCTION 10 0.0004
389 HYPERCALCAEMIA 5 0.0004
390 HYDRONEPHROSIS 3 0.0004
391 TOXIC ENCEPHALOPATHY 2 0.0004
392 TASTE DISORDER 8 0.0004
393 APPENDICITIS PERFORATED 1 0.0004
394 PROCEDURAL COMPLICATION 3 0.0004
395 CANCER PAIN 1 0.0004
396 BLOOD CHLORIDE DECREASED 1 0.0004
397 APLASTIC ANAEMIA 2 0.0004
398 SICKLE CELL ANAEMIA WITH CRISIS 6 0.0004
399 RENAL PAIN 4 0.0004
400 ABDOMINAL MASS 1 0.0004
401 BRADYPNOEA 1 0.0004
402 FRACTURE 7 0.0004
403 POST PROCEDURAL INFECTION 3 0.0004
404 DYSPHAGIA 35 0.0004
405 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
406 BLOOD PHOSPHORUS INCREASED 1 0.0004
407 CEREBRAL HAEMORRHAGE 13 0.0004
408 PROSTATIC DISORDER 2 0.0004
409 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
410 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
411 HAEMOGLOBIN DECREASED 37 0.0004
412 ON AND OFF PHENOMENON 2 0.0004
413 BRADYCARDIA 19 0.0004
414 PULMONARY OEDEMA 16 0.0004
415 FISTULA 4 0.0004
416 MITRAL VALVE INCOMPETENCE 4 0.0004
417 CEREBRAL THROMBOSIS 1 0.0004
418 INTERNAL HAEMORRHAGE 4 0.0003
419 ATRIAL FIBRILLATION 34 0.0003
420 CARDIOGENIC SHOCK 5 0.0003
421 BLOOD URIC ACID INCREASED 2 0.0003
422 MYELODYSPLASTIC SYNDROME 5 0.0003
423 DEAFNESS 9 0.0003
424 BLOOD CALCIUM INCREASED 3 0.0003
425 HYPOVOLAEMIA 2 0.0003
426 ENERGY INCREASED 2 0.0003
427 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
428 THERAPY INTERRUPTED 24 0.0003
429 CREPITATIONS 1 0.0003
430 CHOLECYSTITIS 4 0.0003
431 BRAIN HERNIATION 1 0.0003
432 HYPERLIPIDAEMIA 4 0.0003
433 PROTHROMBIN TIME PROLONGED 2 0.0003
434 GOUT 6 0.0003
435 PERIPHERAL SWELLING 51 0.0003
436 BONE MARROW DISORDER 1 0.0003
437 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
438 TREATMENT NONCOMPLIANCE 18 0.0003
439 INGUINAL HERNIA 2 0.0003
440 BRAIN DEATH 1 0.0003
441 PRODUCT DISTRIBUTION ISSUE 3 0.0003
442 FEELING COLD 9 0.0003
443 OLIGURIA 2 0.0003
444 HEPATIC ENCEPHALOPATHY 3 0.0003
445 APPENDICITIS 3 0.0003
446 BLOOD PRESSURE INCREASED 49 0.0003
447 BLOOD BLISTER 1 0.0003
448 BLOOD CREATININE DECREASED 1 0.0003
449 DRUG-INDUCED LIVER INJURY 10 0.0003
450 INTESTINAL OBSTRUCTION 12 0.0003
451 BREAST CANCER RECURRENT 1 0.0003
452 BILE DUCT STONE 1 0.0003
453 RHABDOMYOLYSIS 13 0.0003
454 HEPATITIS ACUTE 2 0.0003
455 RENAL TUBULAR NECROSIS 3 0.0003
456 LABORATORY TEST ABNORMAL 9 0.0003
457 HOSPICE CARE 3 0.0003
458 SARS-COV-2 TEST POSITIVE 4 0.0003
459 HYPERTENSION 64 0.0003
460 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
461 PRESCRIBED UNDERDOSE 6 0.0003
462 EYE HAEMORRHAGE 4 0.0003
463 SWELLING 28 0.0003
464 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
465 EMPHYSEMA 3 0.0003
466 TYPE 2 DIABETES MELLITUS 10 0.0003
467 HYPOTHERMIA 3 0.0003
468 TACHYPNOEA 4 0.0003
469 PRODUCT PRESCRIBING ERROR 7 0.0003
470 INFARCTION 2 0.0003
471 NEPHROTIC SYNDROME 2 0.0003
472 CARDIAC ARREST 24 0.0003
473 CERVICAL VERTEBRAL FRACTURE 1 0.0003
474 SEPSIS 32 0.0003
475 CAROTID ARTERY STENOSIS 1 0.0003
476 NEOPLASM MALIGNANT 19 0.0003
477 BONE EROSION 1 0.0003
478 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
479 THERMAL BURN 2 0.0003
480 RETINAL HAEMORRHAGE 2 0.0003
481 SUBDURAL HAEMATOMA 4 0.0003
482 DIARRHOEA 180 0.0003
483 DECREASED ACTIVITY 3 0.0003
484 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
485 FAECES DISCOLOURED 6 0.0003
486 LEUKOCYTOSIS 5 0.0003
487 HAEMATEMESIS 7 0.0003
488 OSTEOMYELITIS 5 0.0003
489 SEPTIC SHOCK 12 0.0003
490 FAECES SOFT 2 0.0003
491 CAROTID ARTERY OCCLUSION 1 0.0003
492 CUTANEOUS VASCULITIS 1 0.0003
493 BLOOD PHOSPHORUS DECREASED 1 0.0003
494 ILLNESS 28 0.0003
495 AMYLASE INCREASED 1 0.0003
496 CEREBRAL DISORDER 2 0.0003
497 VENTRICULAR FIBRILLATION 3 0.0003
498 URINARY RETENTION 9 0.0003
499 HYPOTENSION 54 0.0003
500 MALNUTRITION 3 0.0003
501 HYPOGLYCAEMIA 13 0.0003
502 CHRONIC SINUSITIS 1 0.0003
503 HEART RATE IRREGULAR 6 0.0003
504 AUTOIMMUNE THYROIDITIS 1 0.0003
505 HYPOCALCAEMIA 5 0.0003
506 CORONARY ARTERY DISEASE 8 0.0003
507 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
508 DIABETES MELLITUS 20 0.0003
509 ACIDOSIS 2 0.0003
510 INSURANCE ISSUE 4 0.0003
511 COMMUNICATION DISORDER 1 0.0003
512 GASTRIC HAEMORRHAGE 3 0.0003
513 PRODUCT USE ISSUE 49 0.0003
514 POST PROCEDURAL COMPLICATION 5 0.0003
515 CEREBROVASCULAR ACCIDENT 44 0.0003
516 HAEMOLYSIS 2 0.0003
517 ATRIOVENTRICULAR BLOCK 2 0.0003
518 LIMB INJURY 7 0.0003
519 COVID-19 45 0.0003
520 PULMONARY HAEMORRHAGE 2 0.0003
521 BRAIN FOG 4 0.0003
522 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
523 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
524 PRODUCT USE COMPLAINT 4 0.0003
525 ARRHYTHMIA 12 0.0003
526 BLOOD PRESSURE ABNORMAL 5 0.0003
527 WOUND 7 0.0003
528 WRIST FRACTURE 3 0.0003
529 HYPONATRAEMIA 14 0.0002
530 PNEUMONIA 80 0.0002
531 SHOCK HAEMORRHAGIC 2 0.0002
532 CHOLELITHIASIS 8 0.0002
533 VENTRICULAR TACHYCARDIA 4 0.0002
534 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
535 BLOOD PRESSURE DECREASED 16 0.0002
536 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
537 CARDIO-RESPIRATORY ARREST 10 0.0002
538 DERMATITIS ALLERGIC 3 0.0002
539 HAEMODIALYSIS 2 0.0002
540 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
541 ACUTE MYOCARDIAL INFARCTION 7 0.0002
542 SENSATION OF FOREIGN BODY 2 0.0002
543 CARDIAC DISORDER 22 0.0002
544 ABSCESS LIMB 1 0.0002
545 FALL 77 0.0002
546 OXYGEN SATURATION DECREASED 13 0.0002
547 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
548 EPILEPSY 7 0.0002
549 URINARY TRACT INFECTION 39 0.0002
550 EOSINOPHILIA 4 0.0002
551 PULMONARY CONGESTION 3 0.0002
552 IMMUNOSUPPRESSION 2 0.0002
553 ABDOMINAL ABSCESS 1 0.0002
554 ANAL INCONTINENCE 2 0.0002
555 FREQUENT BOWEL MOVEMENTS 6 0.0002
556 ABDOMINAL DISCOMFORT 37 0.0002
557 ABDOMINAL DISTENSION 23 0.0002
558 PRODUCT AVAILABILITY ISSUE 5 0.0002
559 HYPERGLYCAEMIA 8 0.0002
560 CORONARY ARTERY OCCLUSION 3 0.0002
561 MYOCARDIAL INFARCTION 38 0.0002
562 HIP FRACTURE 7 0.0002
563 DEHYDRATION 29 0.0002
564 INCREASED TENDENCY TO BRUISE 2 0.0002
565 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
566 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
567 MENTAL STATUS CHANGES 6 0.0002
568 ARTHRITIS INFECTIVE 1 0.0002
569 THERAPY CESSATION 11 0.0002
570 DIARRHOEA HAEMORRHAGIC 2 0.0002
571 LEUKAEMIA 2 0.0002
572 COLITIS MICROSCOPIC 1 0.0002
573 PRODUCT DOSE OMISSION ISSUE 62 0.0002
574 CARDIAC TAMPONADE 1 0.0002
575 HYPOACUSIS 9 0.0002
576 GLAUCOMA 4 0.0002
577 SINUS BRADYCARDIA 2 0.0002
578 LOCALISED INFECTION 5 0.0002
579 MENTAL IMPAIRMENT 5 0.0002
580 INTENTIONAL PRODUCT MISUSE 18 0.0002
581 VITAMIN D DEFICIENCY 2 0.0002
582 HAEMATURIA 7 0.0002
583 COELIAC DISEASE 2 0.0002
584 SKIN HAEMORRHAGE 3 0.0002
585 HOSPITALISATION 31 0.0002
586 HEPATIC FAILURE 6 0.0002
587 HYPOXIA 7 0.0002
588 DECREASED APPETITE 46 0.0002
589 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
590 MOTOR DYSFUNCTION 2 0.0002
591 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
592 NEUTROPHIL COUNT INCREASED 2 0.0002
593 RIB FRACTURE 4 0.0002
594 POOR VENOUS ACCESS 2 0.0002
595 VENTRICULAR EXTRASYSTOLES 2 0.0002
596 WEIGHT INCREASED 43 0.0002
597 RESPIRATORY FAILURE 14 0.0002
598 CYANOSIS 3 0.0002
599 HEAD INJURY 6 0.0002
600 VOMITING 89 0.0002
601 ANAEMIA 36 0.0002
602 ABSCESS 3 0.0002
603 HYPOTHYROIDISM 6 0.0002
604 RETCHING 4 0.0002
605 SENSORY DISTURBANCE 3 0.0002
606 COMPRESSION FRACTURE 1 0.0002
607 RECTAL HAEMORRHAGE 8 0.0002
608 DYSPNOEA EXERTIONAL 7 0.0002
609 HOT FLUSH 14 0.0002
610 VISUAL IMPAIRMENT 23 0.0002
611 BRUXISM 1 0.0002
612 RASH PRURITIC 10 0.0002
613 SKIN LACERATION 2 0.0002
614 PULMONARY THROMBOSIS 2 0.0002
615 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
616 WOUND INFECTION 2 0.0002
617 JOINT SWELLING 22 0.0002
618 GASTROINTESTINAL PAIN 2 0.0002
619 MELAENA 4 0.0002
620 DEAFNESS UNILATERAL 1 0.0002
621 CHOKING SENSATION 1 0.0002
622 RESPIRATORY DISTRESS 5 0.0002
623 CYSTIC FIBROSIS 1 0.0002
624 CYTOMEGALOVIRUS INFECTION 3 0.0002
625 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
626 TRANSAMINASES INCREASED 4 0.0002
627 ANGIOPATHY 1 0.0002
628 PLATELET COUNT DECREASED 19 0.0002
629 OCULAR DISCOMFORT 2 0.0002
630 CHROMATURIA 4 0.0002
631 COLECTOMY 1 0.0002
632 CHOLECYSTITIS ACUTE 1 0.0002
633 CHEST DISCOMFORT 18 0.0002
634 ASTHENIA 66 0.0002
635 RED BLOOD CELL COUNT DECREASED 5 0.0002
636 MYOCARDITIS 2 0.0002
637 SHOCK 4 0.0002
638 CORONARY ARTERY BYPASS 1 0.0002
639 METASTASES TO LUNG 2 0.0002
640 PERICARDIAL EFFUSION 4 0.0002
641 NEUTROPHIL COUNT DECREASED 7 0.0002
642 SPLENOMEGALY 2 0.0002
643 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
644 DECREASED INTEREST 1 0.0002
645 BRADYKINESIA 1 0.0002
646 SWELLING FACE 11 0.0002
647 ISCHAEMIC STROKE 3 0.0002
648 MACULAR DEGENERATION 2 0.0002
649 GASTROINTESTINAL DISORDER 15 0.0002
650 MUSCULAR WEAKNESS 19 0.0002
651 GASTROENTERITIS VIRAL 3 0.0002
652 HEPATITIS C 2 0.0002
653 ADRENAL INSUFFICIENCY 2 0.0002
654 CYTOPENIA 2 0.0002
655 DYSURIA 6 0.0002
656 BLOOD GLUCOSE ABNORMAL 3 0.0002
657 THROMBOSIS 13 0.0002
658 FEMUR FRACTURE 5 0.0002
659 CHOLANGITIS 1 0.0002
660 BACTERIAL INFECTION 3 0.0002
661 HEPATIC FUNCTION ABNORMAL 6 0.0002
662 AGEUSIA 4 0.0002
663 HEPATIC CIRRHOSIS 3 0.0002
664 INFECTION 23 0.0002
665 CELLULITIS 8 0.0002
666 COLITIS 6 0.0002
667 MUSCULOSKELETAL DISORDER 3 0.0002
668 CYSTITIS 5 0.0002
669 INCREASED APPETITE 3 0.0002
670 HYPOPHAGIA 4 0.0002
671 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
672 LOWER LIMB FRACTURE 3 0.0002
673 SEIZURE 18 0.0002
674 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
675 ERUCTATION 3 0.0002
676 ABDOMINAL PAIN 36 0.0002
677 SKIN ULCER 4 0.0002
678 CARDIAC FLUTTER 1 0.0002
679 HAEMATOMA 4 0.0002
680 ANGINA UNSTABLE 1 0.0002
681 SKIN FISSURES 3 0.0002
682 PLATELET COUNT INCREASED 2 0.0002
683 KIDNEY INFECTION 3 0.0002
684 GASTRITIS 4 0.0002
685 CORONAVIRUS INFECTION 1 0.0002
686 APPETITE DISORDER 1 0.0002
687 LIP SWELLING 5 0.0001
688 SPINAL FRACTURE 3 0.0001
689 MALIGNANT MELANOMA 2 0.0001
690 MUSCLE SPASMS 27 0.0001
691 BODY TEMPERATURE INCREASED 3 0.0001
692 ABNORMAL LOSS OF WEIGHT 1 0.0001
693 CHEST PAIN 27 0.0001
694 OFF LABEL USE 127 0.0001
695 INTERSTITIAL LUNG DISEASE 7 0.0001
696 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
697 POLLAKIURIA 6 0.0001
698 HYPOMAGNESAEMIA 2 0.0001
699 PANCYTOPENIA 8 0.0001
700 LUNG DISORDER 7 0.0001
701 CARPAL TUNNEL SYNDROME 2 0.0001
702 DEFAECATION URGENCY 1 0.0001
703 BLOOD TEST ABNORMAL 2 0.0001
704 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
705 HEART RATE INCREASED 14 0.0001
706 FLATULENCE 8 0.0001
707 ABDOMINAL PAIN UPPER 29 0.0001
708 SINUS TACHYCARDIA 2 0.0001
709 JOINT INJURY 3 0.0001
710 INTENTIONAL DOSE OMISSION 4 0.0001
711 LIVER FUNCTION TEST INCREASED 3 0.0001
712 HYPERSOMNIA 4 0.0001
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
714 BALANCE DISORDER 12 0.0001
715 PARAESTHESIA ORAL 2 0.0001
716 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
717 HYPOKINESIA 2 0.0001
718 LIVER FUNCTION TEST ABNORMAL 4 0.0001
719 APATHY 2 0.0001
720 GASTROENTERITIS 2 0.0001
721 DYSSTASIA 4 0.0001
722 UNDERDOSE 10 0.0001
723 DYSPNOEA 77 0.0001
724 GAIT DISTURBANCE 26 0.0001
725 INFLAMMATION 7 0.0001
726 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
727 BRONCHITIS 10 0.0001
728 ARTHROPOD BITE 1 0.0001
729 IMMUNODEFICIENCY 2 0.0001
730 APHASIA 4 0.0001
731 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
732 DELUSION 2 0.0001
733 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
734 THERAPY PARTIAL RESPONDER 2 0.0001
735 HAEMATOCHEZIA 7 0.0001
736 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
737 DISORIENTATION 5 0.0001
738 ATRIAL FLUTTER 1 0.0001
739 BLOOD GLUCOSE DECREASED 6 0.0001
740 COUGH 35 0.0001
741 PRESYNCOPE 3 0.0001
742 ASPHYXIA 1 0.0001
743 ENCEPHALOPATHY 3 0.0001
744 METASTASES TO BONE 2 0.0001
745 TREMOR 20 0.0001
746 EPISTAXIS 9 0.0001
747 DIZZINESS 60 0.0001
748 GAIT INABILITY 4 0.0001
749 PALPITATIONS 14 0.0001
750 CHILLS 14 0.0001
751 NAUSEA 94 0.0001
752 ABDOMINAL PAIN LOWER 3 0.0001
753 FACE OEDEMA 2 0.0001
754 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
755 CATARACT 7 0.0001
756 LOSS OF CONSCIOUSNESS 15 0.0001
757 UNRESPONSIVE TO STIMULI 3 0.0001
758 ANURIA 1 0.0001
759 BLOOD MAGNESIUM DECREASED 1 0.0001
760 PYREXIA 40 0.0001
761 CARDIAC MURMUR 1 0.0001
762 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
763 ORTHOSTATIC HYPOTENSION 2 0.0001
764 DISCOMFORT 7 0.0001
765 ARTHRITIS 9 0.0001
766 DEVICE USE ISSUE 2 0.0001
767 NEUROTOXICITY 2 0.0001
768 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
769 DRUG ERUPTION 2 0.0001
770 LIVER DISORDER 5 0.0001
771 THIRST 2 0.0001
772 COLITIS ULCERATIVE 5 0.0001
773 DYSPEPSIA 11 0.0001
774 CONFUSIONAL STATE 18 0.0001
775 MYELOSUPPRESSION 4 0.0001
776 DRY MOUTH 9 0.0001
777 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
778 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
779 NEPHROLITHIASIS 5 0.0001
780 BRAIN NEOPLASM 1 0.0001
781 RESPIRATORY ARREST 3 0.0001
782 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
783 HAEMOPTYSIS 3 0.0001
784 EYE SWELLING 4 0.0001
785 EYE PAIN 6 0.0001
786 HALLUCINATION 8 0.0001
787 BLOOD GLUCOSE INCREASED 20 0.0001
788 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
789 FOOT FRACTURE 2 0.0001
790 RENAL CANCER 5 0.0001
791 CHOLESTASIS 2 0.0001
792 HERNIA 2 0.0001
793 HEPATIC ENZYME INCREASED 7 0.0001
794 MALAISE 45 0.0001
795 AUTOIMMUNE DISORDER 1 0.0001
796 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
797 HAEMORRHOIDS 2 0.0001
798 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
799 RENAL INJURY 3 0.0001
800 WEIGHT DECREASED 28 0.0001
801 RESPIRATORY DISORDER 3 0.0001
802 SYNCOPE 10 0.0001
803 AGGRESSION 5 0.0001
804 CYTOKINE RELEASE SYNDROME 2 0.0001
805 SLEEP DISORDER 7 0.0001
806 PRODUCT PHYSICAL ISSUE 2 0.0001
807 PRODUCT ADMINISTRATION ERROR 2 0.0001
808 ILL-DEFINED DISORDER 6 0.0001
809 DYSKINESIA 4 0.0001
810 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
811 PERITONITIS 2 0.0001
812 SWOLLEN TONGUE 3 0.0001
813 PULMONARY HYPERTENSION 2 0.0001
814 NERVOUSNESS 5 0.0001
815 PAIN IN EXTREMITY 28 0.0001
816 MEMORY IMPAIRMENT 13 0.0001
817 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
818 BREAST PAIN 1 0.0001
819 HYPOAESTHESIA 14 0.0001
820 BODY HEIGHT DECREASED 1 0.0001
821 IRRITABLE BOWEL SYNDROME 2 0.0001
822 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
823 BIPOLAR DISORDER 1 0.0001
824 BACK INJURY 1 0.0001
825 FEELING ABNORMAL 22 0.0001
826 ANGIOEDEMA 4 0.0001
827 RASH MACULO-PAPULAR 2 0.0001
828 NECK PAIN 5 0.0001
829 THERAPY NON-RESPONDER 4 0.0001
830 HERPES ZOSTER 5 0.0001
831 LETHARGY 5 0.0001
832 DELIRIUM 3 0.0001
833 DYSPHONIA 5 0.0001
834 HEART RATE DECREASED 3 0.0001
835 BONE PAIN 5 0.0001
836 SURGERY 5 0.0001
837 FATIGUE 66 0.0001
838 COVID-19 PNEUMONIA 1 0.0001
839 TREATMENT FAILURE 7 0.0001
840 PRODUCTIVE COUGH 4 0.0001
841 ACCIDENT 1 0.0001
842 BLOOD PRESSURE FLUCTUATION 2 0.0001
843 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
844 HEPATIC CANCER 2 0.0001
845 DRUG INTOLERANCE 8 0.0001
846 PANIC ATTACK 3 0.0001
847 BACK PAIN 19 0.0001
848 LIVER INJURY 2 0.0001
849 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
850 GASTRIC CANCER 2 0.0001
851 CARDIOVASCULAR DISORDER 2 0.0001
852 PRURITUS 30 0.0001
853 RASH 34 0.0001
854 PLASMA CELL MYELOMA 3 0.0001
855 PRODUCT DOSE OMISSION 5 0.0001
856 HAEMORRHAGE 8 0.0001
857 SPEECH DISORDER 4 0.0001
858 JOINT STIFFNESS 2 0.0001
859 ANHEDONIA 2 0.0001
860 EAR INFECTION 2 0.0001
861 PROSTATE CANCER 6 0.0001
862 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
863 THROAT TIGHTNESS 2 0.0001
864 PNEUMONITIS 2 0.0001
865 MOOD ALTERED 2 0.0001
866 MIGRAINE 7 0.0001
867 ACUTE HEPATIC FAILURE 1 0.0001
868 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
869 LUNG NEOPLASM MALIGNANT 3 0.0001
870 SKIN LESION 2 0.0001
871 INFLUENZA LIKE ILLNESS 6 0.0001
872 CONTUSION 7 0.0001
873 DIVERTICULITIS 2 0.0001
874 ROAD TRAFFIC ACCIDENT 3 0.0001
875 THROMBOCYTOPENIA 8 0.0001
876 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
877 ANGINA PECTORIS 2 0.0001
878 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
879 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
880 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
881 AGITATION 5 0.0001
882 DISEASE PROGRESSION 8 0.0001
883 URINARY INCONTINENCE 2 0.0001
884 DYSGEUSIA 5 0.0001
885 THROAT IRRITATION 3 0.0001
886 LACRIMATION INCREASED 2 0.0001
887 NEUTROPENIA 9 0.0001
888 VERTIGO 4 0.0001
889 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
890 LIMB DISCOMFORT 2 0.0001
891 ANKLE FRACTURE 1 0.0001
892 SOMNOLENCE 13 0.0001
893 COGNITIVE DISORDER 3 0.0001
894 BASAL CELL CARCINOMA 1 0.0001
895 NERVOUS SYSTEM DISORDER 2 0.0001
896 BONE DENSITY DECREASED 2 0.0001
897 MOOD SWINGS 2 0.0001
898 ARTHRALGIA 26 0.0001
899 RHINORRHOEA 4 0.0001
900 IMPAIRED HEALING 2 0.0001
901 EYE DISORDER 2 0.0001
902 EXPIRED PRODUCT ADMINISTERED 2 0.0001
903 DRY EYE 3 0.0001
904 COAGULOPATHY 1 0.0001
905 LEUKOPENIA 3 0.0001
906 CANDIDA INFECTION 1 0.0001
907 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
908 ANGER 2 0.0001
909 CIRCULATORY COLLAPSE 1 0.0001
910 SINUSITIS 6 0.0001
911 DRUG INEFFECTIVE 77 0.0001
912 GASTRIC DISORDER 2 0.0001
913 NEOPLASM PROGRESSION 2 0.0001
914 PRODUCT STORAGE ERROR 5 0.0001
915 MUSCULOSKELETAL STIFFNESS 5 0.0001
916 PAIN 35 0.0001
917 INJURY 4 0.0001
918 LYMPHADENOPATHY 2 0.0001
919 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
920 TACHYCARDIA 5 0.0001
921 ANXIETY 16 0.0001
922 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
923 HYPERHIDROSIS 7 0.0001
924 CONJUNCTIVITIS 1 0.0001
925 AGRANULOCYTOSIS 1 0.0001
926 DYSARTHRIA 2 0.0001
927 UNEVALUABLE EVENT 4 0.0001
928 BLOOD URINE PRESENT 1 0.0001
929 CONDITION AGGRAVATED 16 0.0001
930 NASAL CONGESTION 3 0.0001
931 HEADACHE 32 0.0001
932 VISION BLURRED 7 0.0001
933 STOMATITIS 3 0.0000
934 EXTRA DOSE ADMINISTERED 2 0.0000
935 BONE MARROW FAILURE 1 0.0000
936 NASOPHARYNGITIS 9 0.0000
937 HYPERSENSITIVITY 9 0.0000
938 INCORRECT DOSE ADMINISTERED 11 0.0000
939 SKIN EXFOLIATION 4 0.0000
940 MYALGIA 8 0.0000
941 DEEP VEIN THROMBOSIS 3 0.0000
942 AMNESIA 3 0.0000
943 FEBRILE NEUTROPENIA 3 0.0000
944 INFLUENZA 5 0.0000
945 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
946 NO ADVERSE EVENT 8 0.0000
947 ERYTHEMA 9 0.0000
948 TINNITUS 2 0.0000
949 SKIN DISCOLOURATION 2 0.0000
950 OROPHARYNGEAL PAIN 4 0.0000
951 BLOOD CHOLESTEROL INCREASED 2 0.0000
952 OCULAR HYPERAEMIA 2 0.0000
953 NEUROPATHY PERIPHERAL 4 0.0000
954 RASH ERYTHEMATOUS 2 0.0000
955 URTICARIA 7 0.0000
956 MOBILITY DECREASED 3 0.0000
957 OVERDOSE 9 0.0000
958 INSOMNIA 11 0.0000
959 ACNE 3 0.0000
960 FLUSHING 4 0.0000
961 ECZEMA 2 0.0000
962 PARAESTHESIA 6 0.0000
963 DRY SKIN 5 0.0000
964 DISTURBANCE IN ATTENTION 2 0.0000
965 BLOOD BILIRUBIN INCREASED 1 0.0000
966 ANAPHYLACTIC REACTION 2 0.0000
967 MEDICATION ERROR 2 0.0000
968 BLISTER 2 0.0000
969 RHEUMATOID ARTHRITIS 4 0.0000
970 EYE IRRITATION 2 0.0000
971 WHEEZING 2 0.0000
972 ADVERSE DRUG REACTION 3 0.0000
973 THERAPEUTIC RESPONSE DECREASED 2 0.0000
974 ADVERSE EVENT 3 0.0000
975 PULMONARY EMBOLISM 3 0.0000
976 INTENTIONAL OVERDOSE 2 0.0000
977 DEPRESSION 7 0.0000
978 ALOPECIA 6 0.0000
979 BURNING SENSATION 2 0.0000
980 DEVICE MALFUNCTION 2 0.0000
981 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
982 C-REACTIVE PROTEIN INCREASED 1 0.0000
983 EMOTIONAL DISTRESS 3 0.0000
984 DEVICE ISSUE 2 0.0000
985 DRUG DEPENDENCE 3 0.0000
986 ASTHMA 2 0.0000
987 BLADDER CANCER 1 0.0000
988 PRODUCT QUALITY ISSUE 2 0.0000
989 DRUG INTERACTION 2 0.0000
990 BREAST CANCER 1 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000